Loading...
Loading...
CDC PLACES (2023, crude) estimates 9.5% of adults in Lincoln have diagnosed diabetes — 2.5 points below the U.S. 12% figure. Census population 291,082. Nebraska Medicare wound biologics: WPS Government Health Administrators (J5). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Lincoln clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Lincoln storefront.
361 HCT/P Compliant Tissue Products in Lincoln, NE for clinics & physicians. Exclusively 361 HCT/P complia… Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 9.5% of adults in Lincoln have diagnosed diabetes — 2.5 points below the U.S. 12% figure. Obesity 35.1%; arthritis 22%. Those three PLACES crude rates (plus Census 291,082) are the local facts on this page. Everything else is the national 361 hctp compliant products catalog and J5 paperwork.
National 361 HCT/P Compliant Tissue Products notes (how the product actually works)9.6% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. A city of 250k–500k with 291,082 residents will still mix those payers. CDC PLACES (2023, crude) estimates 9.5% of adults in Lincoln have diagnosed diabetes — 2.5 points below the U.S. 12% figure. Build two utilization policies if you do both cash PRP and Medicare CTPs.
Named person, real rates, no fake address. Joe Bradley, founder, active practice owner. CDC PLACES (2023, crude) estimates 9.5% of adults in Lincoln have diagnosed diabetes — 2.5 points below the U.S. 12% figure. Adult arthritis here is 22% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Schema on this site does not publish a fabricated star rating for Lincoln.
CDC PLACES (2023, crude prevalence) estimates 9.5% of adults — 2.5 points below the U.S. 12% figure. Obesity is 35.1%; arthritis is 22%. That is place-level BRFSS modeling, not a clinic census and not a Lincoln trial.
No. PRP (autologous) and cellular/tissue products (allograft/skin substitutes) sit on different coding and coverage paths. WPS Government Health Administrators LCDs for CTPs do not automatically cover PRP injections. Build separate protocols and fee tickets.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a Nebraska compliance risk.
Start with one protocol — one joint or one wound type — for 90 days. CDC PLACES (2023, crude) estimates 9.5% of adults in Lincoln have diagnosed diabetes — 2.5 points below the U.S. 12% figure. Name a staff owner for photos, lots, and centrifuge logs. Then expand the fridge.
Contact us to learn how Hawk Medical supports practices in Lincoln, NE.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Lincoln is J5 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Lincoln — 2.5 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Nebraska Part B wound biologics follow this contractor (siblings: IA, KS, MO). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Lincoln. Useful for joint-program math; still needs a diagnosis and privileging.
No Lincoln storefront. Joe Bradley is an active practice owner. 361 hctp compliant products stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.